Blocking fatty ceramides could stop acute kidney injury—and possibly revolutionize mitochondrial disease treatment.

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Chronic kidney disease is a gradual, irreversible loss of kidney function caused by diabetes, hypertension, or ageing. It ...

3D printing technology enables precise drug design, personalized dosing, and versatile release modes, benefiting patient-centric treatments. At AAPS PharmSci 360, Xialing Li, PhD, says 3D-printed ...

Discovering the link between congenital heart disease and kidney problems could improve outcomes for patients with the ...

A research team at the University of Pittsburgh, led by Dr. Anne Robertson and PhD candidate Fatemeh Azari, discovered that the bladder does not simply inflate like a balloon when it fills. Instead, ...

A multi‐centre Ghanaian study found that the prevalence of CKD in people with hypertension and/or diabetes was rising; the ...

When we think of our health, we tend to consider our bodies as a whole rather than looking at each individual organ. But it's essential to understand the role each body part plays in maintaining our ...

Researchers from Michigan Medicine recently studied how type 2 diabetes could change the brain’s structure and function over ...

A 21-year-old man in Turkey suffered a severe and potentially deadly disease after following a bizarre habit to try to ...